Audit 412145

FY End
2025-12-31
Total Expended
$1.57M
Findings
0
Programs
2
Organization: Naprogenix, Inc. (KY)
Year: 2025 Accepted: 2026-09-25
Auditor: 273858252

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.273 ALCOHOL RESEARCH PROGRAMS $1.17M Yes 0
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $404,667 Yes 0

Contacts

Name Title Type
N1NBJ43SQGX7 Cindy Burklow Auditee
8592571127 Megan Crane Auditor
No contacts on file

Notes to SEFA

award activity of Naprogenix, Inc. (the Company) under programs of the federal government for the year ended December 31, 2025. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Regulations, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Company, it is not intended to and does not present the financial position, changes in stockholders' deficit, or cash flows of the Company.